CORDIS
EU research results

CORDIS

English EN

European Lipidomics Initiative

Project information

Grant agreement ID: 13032

  • Start date

    1 January 2005

  • End date

    30 June 2007

Funded under:

FP6-LIFESCIHEALTH

  • Overall budget:

    € 487 200

  • EU contribution

    € 487 200

Coordinated by:

UTRECHT UNIVERSITY, CENTRE FOR BIOMEMBRANES AND LIPID ENZYMOLOGY

Netherlands

Objective

Over the past ten years, technological developments have caused a revolution in the fields of genomics and proteomics. Suitable technologies are now emerging for the field of Metabolomics. It is a challenge to bring the essential actors together at the European level to devise strategies on how to develop the field of Metabolomics in connection with genomics and proteomics. The present proposal aims to do so by taking the sub-field of Lipidomics as an example. Here, the major new technology is high throughput mass spectrometry, which is now on the verge of being applied to diseases related to the lipidome. To mobilize and network the European basic and medical researchers and industry, a series of dedicated workshops and a concluding conference will be organized on technology development, scientific challenges and medical applications of Lipidomics. One aim is to create a European technology platform bringing together technological know-how and industry. The second aim is to shape the way in which Metabolomics research and in particular Lipidomics research is organised in Europe. Finally, we aim at defining the most suitable ways in which the new technologies can be applied in the clinical setting to assess, cure and prevent membrane lipid disorders.

Coordinator

UTRECHT UNIVERSITY, CENTRE FOR BIOMEMBRANES AND LIPID ENZYMOLOGY

Address

Padualaan 8
Utrecht

Netherlands

Participants (13)

UNIVERSITY HOSPITAL REGENSBURG

Germany

MAX-PLANCK-GESELLSCHAFT ZUR FÖRDERUNG DER WISSENSCHAFTEN E.V.

Germany

FRAUNHOFER GESELLSCHAFT FÜR ANGEWANDTE FORSCHUNG E.V.

Germany

THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD

United Kingdom

GOTEBORG UNIVERSITY

Sweden

UNIVERSIDAD DEL PAÍS VASCO/EUSKAL HERRIKO UNIBERTSITATEA

Spain

UNIVERSITY OF HELSINKI

Finland

INSTITUT NATIONAL DES SCIENCES APPLIQUÉES DE LYON

France

RHEINISCHE FRIEDRICH-WILHELMS UNIVERSITÄT BONN

Germany

NATIONAL MEDICAL CENTER, INSTITUTE OF HAEMATOLOGY AND IMMUNOLOGY

Hungary

UNIVERSITÄT GRAZ

Austria

UNIVERSITY OF MILAN

Italy

MEDICAL UNIVERSITY INNSBRUCK

Austria

Project information

Grant agreement ID: 13032

  • Start date

    1 January 2005

  • End date

    30 June 2007

Funded under:

FP6-LIFESCIHEALTH

  • Overall budget:

    € 487 200

  • EU contribution

    € 487 200

Coordinated by:

UTRECHT UNIVERSITY, CENTRE FOR BIOMEMBRANES AND LIPID ENZYMOLOGY

Netherlands